iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by KCM Investment Advisors LLC

KCM Investment Advisors LLC reduced its position in iShares Biotechnology ETF (NASDAQ:IBB) by 2.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 20,381 shares of the financial services provider’s stock after selling 469 shares during the quarter. KCM Investment Advisors LLC’s holdings in iShares Biotechnology ETF were worth $2,967,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in IBB. Highline Wealth Partners LLC acquired a new stake in iShares Biotechnology ETF in the 3rd quarter worth approximately $30,000. Bbjs Financial Advisors LLC acquired a new stake in iShares Biotechnology ETF during the second quarter valued at $31,000. Ashton Thomas Securities LLC purchased a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at about $36,000. Voisard Asset Management Group Inc. purchased a new stake in shares of iShares Biotechnology ETF in the third quarter valued at approximately $59,000. Finally, Aptus Capital Advisors LLC raised its position in iShares Biotechnology ETF by 36.5% during the third quarter. Aptus Capital Advisors LLC now owns 426 shares of the financial services provider’s stock worth $62,000 after acquiring an additional 114 shares during the period. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Down 4.8 %

Shares of iShares Biotechnology ETF stock opened at $133.38 on Friday. iShares Biotechnology ETF has a twelve month low of $116.70 and a twelve month high of $150.57. The firm’s 50-day moving average price is $144.49 and its 200 day moving average price is $141.59.

iShares Biotechnology ETF Announces Dividend

The firm also recently announced a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.